Lindbrook Capital’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-12
Closed -$1.96K 2782
2023
Q3
$1.96K Buy
12
+3
+33% +$708 ﹤0.01% 2137
2023
Q2
$2.8K Sell
9
-4
-31% -$1.22K ﹤0.01% 2026
2023
Q1
$3.46K Sell
13
-7
-35% -$2.57K ﹤0.01% 2016
2022
Q4
$7.64K Sell
20
-9
-31% -$2.54K ﹤0.01% 1568
2022
Q3
$7K Buy
29
+14
+93% +$3.75K ﹤0.01% 1503
2022
Q2
$3K Buy
15
+4
+36% +$1.72K ﹤0.01% 1817
2022
Q1
$8K Buy
+11
New +$6.62K ﹤0.01% 1392

Other funds holding OM

Lindbrook Capital's OM Position: Q4 2023 in Review

Lindbrook Capital sold out of Outset Medical (OM) in Q4 2023, closing a stake of 12 shares — an estimated $1.96K sold.

Lindbrook Capital first reported a position in OM in Q1 2022 and held it in 7 quarters. The position peaked at $8K in Q1 2022. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

  • Lindbrook Capital reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
  • Lindbrook Capital sold 12 Outset Medical shares in Q4 2023, an estimated $1.96K.
  • Lindbrook Capital first reported a position in Outset Medical in Q1 2022 and held it in 7 quarters.
  • Lindbrook Capital's Outset Medical position peaked at $8K in Q1 2022.
  • 140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Lindbrook Capital's 13F filing for Q4 2023, filed 1 Feb 2024.